New DNA repair test could revolutionize treatment for genetic disorders and cancers

NewsGuard 100/100 Score

A personalized test that tells how well chemotherapy, radiotherapy or gene therapy will work on individual patients is now approved for UK, US, EU and Japanese patents.

New DNA repair test could revolutionize treatment for genetic disorders and cancers

Image Credit: Testavec

It will give many people with serious diseases like cancer, heart disease, HIV and cystic fibrosis the choice to opt out of gruelling rounds of treatment that, for them, has a very slim chance of working.

Many genetic diseases like these happen when genes malfunction. Gene therapy aims to get correct copies of malfunctioning genes into patients’ targeted cells, then set them live. But the body's natural ability to repair its own DNA varies greatly from person to person.

Developed by Brunel University London and marketed by spinout company Testavec Ltd, DiNArep, which tests a patient’s ability to repair their DNA, gives a crucial clue on how they’ll react to different kinds of treatment and what will work best for that person. The ground-breaking test already patented in Japan has been awarded a second patent spanning 40 European countries.

“With the DiNArep test, it should be possible to optimise chemotherapy on an individual basis,” said Brunel’s Professor Mike Themis. “Testing a patient’s ability to repair their DNA when faced with a number of different chemotherapies enables the optimal one to be chosen. This could speed up recovery and reduce the ‘hit or miss’ approach currently used for treatment selection.”

The tests could be offered by local hospitals, says Prof Themis, adding: “they are rapid and inexpensive and could lead to much better patient outcomes.”

Chemotherapy is an aggressive treatment used to kill cancer cells – but it damages normal other cells as well. These tests could also be used for radiotherapy, letting medics optimise treatment to find the precise dose each patient can take before their normal cells can no longer repair themselves.

Gene repair capacity is also critical when giving gene therapy, which is used only to treat serious diseases such as cancers, heart disease and HIV infection. This is because gene therapy uses an engineered non-harmful version of a virus to carry the vital correct copy of the malfunctioning gene that caused the disease into the patient’s target cells by splitting open their chromosomes. So poor ability to repair DNA could lead the treatment to fail.

Another completely separate reason ability to repair DNA is important is that it can also flag up if someone is susceptible to cancer.

The ability to discover a patient's DNA repair capabilities has the potential to revolutionise the treatment strategies for genetic disorders and inherited diseases enabling more precise and effective therapeutic interventions.”

Robert Spencer, Executive Chair, Testavec Ltd

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers map early genetic development of the brain